Ipilimumab induced digital vasculitis

BACKGROUND: Immune check point inhibitors (ICIs) have emerged as a new therapeutic paradigm for a variety of malignancies including metastatic melanoma. As the use of ICIs expand, immune-mediated adverse events are becoming a common occurrence. CASE PRESENTATION: We describe the first reported patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Padda, Amrita, Schiopu, Elena, Sovich, Justin, Ma, Vincent, Alva, Ajjai, Fecher, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809839/
https://www.ncbi.nlm.nih.gov/pubmed/29433584
http://dx.doi.org/10.1186/s40425-018-0321-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809839/
https://www.ncbi.nlm.nih.gov/pubmed/29433584
http://dx.doi.org/10.1186/s40425-018-0321-2

Ejemplares similares